Xin Qiao, Zhuo-Chao Zhou, Rui Niu, Yu-Tong Su, Yue Sun, Hong-Lei Liu, . . . Xiao-Bing Cheng. (2019). Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism. Frontiers Media S.A..
Chicago Style (17th ed.) CitationXin Qiao, et al. Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism. Frontiers Media S.A., 2019.
MLA (9th ed.) CitationXin Qiao, et al. Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism. Frontiers Media S.A., 2019.
Warning: These citations may not always be 100% accurate.